This is a critical abstract of an economic evaluation that meets the criteria for inclusion on NHS EED. Each abstract contains a brief summary of the methods, the results and conclusions followed by a detailed critical assessment on the reliability of the study and the conclusions drawn.
Validity of estimate of measure of effectiveness
The authors carried out a systematic review of the smoking and smoking cessation related literature. They clearly identified the outcomes that informed their search, the search terms and sources. Quit rates were adjusted to correct for the natural rate of cessation, a potential confounding factor. Meta-analysis results were used when possible and the authors provided a clear report of which estimates had come from which sources. More information could have been provided about the study population and sample, for instance were individuals known to smoke targeted to receive help or did individuals self select by presenting to primary care with an expressed wish to give up smoking. This factor might have influenced the effectiveness results. Finally, an interesting statistic would have been the number of times that individuals had tried to quit, as this might also have been a potential confounding factor; this factor was highlighted in the authors' discussion.
Validity of estimate of measure of benefit
The quit rate was used as the summary measure of health benefit. This provides a measure that is easily comparable with other technologies used to assess smoking cessation or the cessation of other health impacting activities.
Validity of estimate of costs
The cost analysis was carried out from the perspective of the government and elements relative to this perspective were included. For instance, the authors explicitly reported excluding co-payments by individuals and including the costs of training, salaries, benefits and infrastructure cost. The authors could have been more explicit about the time horizon of the study as this may have a significant impact on the results. Extensive sensitivity analyses demonstrated the robustness of the results to changes in costs.
Other issues
The authors did not make specific comparisons of their results with other studies although, during their background discussion, they did highlight the uncertainties surrounding cost-effectiveness due to conflicting results from previous work. The issue of generalisability was not explicitly addressed, although this was greatly improved by the use of extensive sensitivity analysis and including resource use from a range of studies. The methods of the review and associated results were clearly set out and were transparent. The conclusions were an accurate reflection of both the results presented and the scope of the study. A number of limitations were discussed. For example, the assumption that all smokers are a homogeneous treatment population and the use of single studies to inform some effectiveness estimates where limited evidence was available.
Implications of the study
The authors discussed the relative merits for funding efforts of smoking cessation efforts and reported that investment in proactive telephone counselling would be a cost-effective strategy. Further work on comprehensive economic evaluations of all approaches to smoking cessation is recommended. Future work could also consider the individual patient perspective.
